RecruitingNCT04741906

Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication


Sponsor

Copenhagen University Hospital at Herlev

Enrollment

225 participants

Start Date

Aug 1, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Aim of the study is to examine the feasibility of dental implant insertion in patients receiving high, adjuvant and low dose \> 4 years.


Eligibility

Inclusion Criteria4

  • Patient with cancer or osteoporosis, treated with antiresorptive treatment.
  • The patients should have sufficient compliance, this includes willingness to have the planned assessments
  • The patient should have an expected life span at enrollment of at least 2 years.
  • The local bone quality and quantity should be sufficient for implant insertion without bone augmentation and is classified according to the classification by Cawood \& Howell 1988.

Exclusion Criteria8

  • \> 10 cigarettes daily
  • HbA1c \> 53 mmol/mol
  • Poor oral hygiene
  • Poor general condition: ECOG score 3 or 4.
  • Poor prognosis: Expected survival \<2 year is an exclusion cause.
  • Presence of metastases of the liver brain.
  • Poor local jaw bone quality acc. to Cawood classification stage 3 or 4.
  • Unwillingness to comply with the planned assessments and recordings

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREDental implant surgery

Dental surgery in patients treated with antiresorptive medication

PROCEDUREProsthetic treatment

Prosthetic treatment and loading of the dental implants


Locations(1)

Copenhagen University Hospital, Maxillofacial Department

Copenhagen, Danmark, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04741906


Related Trials